{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:30:21Z","timestamp":1791232221432,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":2434,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1111\/j.1469-0691.2007.01910.x","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T00:15:08Z","timestamp":1204762508000},"page":"298-306","source":"Crossref","is-referenced-by-count":80,"title":["Reducing antibiotic use in influenza: challenges and rewards"],"prefix":"10.1016","volume":"14","author":[{"given":"D.","family":"Low","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01910.x_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-134-6-200103200-00014","article-title":"Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults","volume":"134","author":"Snow","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/315320","article-title":"The impact of influenza epidemics on hospitalizations","volume":"181","author":"Simonsen","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/JVI.80.4.1629-1636.2006","article-title":"Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner","volume":"80","author":"Avadhanula","year":"2006","journal-title":"J Virol"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/arrd.1986.134.5.1040","article-title":"Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A\/PR8 virus","volume":"134","author":"Plotkowski","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4899-0179-8_16","article-title":"PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells","volume":"416","author":"Cundell","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib7","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1128\/IAI.00789-06","article-title":"Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection","volume":"74","author":"McNamee","year":"2006","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib8","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.4049\/jimmunol.172.12.7603","article-title":"IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection","volume":"172","author":"van der Sluijs","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/IAI.68.2.921-924.2000","article-title":"Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model","volume":"68","author":"Tong","year":"2000","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib10","doi-asserted-by":"crossref","first-page":"D877","DOI":"10.2741\/A649","article-title":"Molecular pathogenesis of pneumococcal pneumonia","volume":"6","author":"McCullers","year":"2001","journal-title":"Front Biosci"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s100960000376","article-title":"Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom","volume":"19","author":"Meier","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib12","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","article-title":"Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations","volume":"163","author":"Kaiser","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib13","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/bmj.306.6890.1452","article-title":"What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H3N2 influenza A in general practice","volume":"306","author":"Connolly","year":"1993","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/fampra\/18.6.629","article-title":"The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in Italy","volume":"18","author":"Sessa","year":"2001","journal-title":"Fam Pract"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bmj.308.6940.1341","article-title":"Influenza: diagnosis, management, and prophylaxis","volume":"308","author":"Wiselka","year":"1994","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1532-5415.2002.50153.x","article-title":"Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999\u20132000","volume":"50","author":"Bowles","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib18","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1016\/j.vaccine.2006.05.006","article-title":"Impact of influenza infection in healthy children examined as outpatients and their families","volume":"24","author":"Tsolia","year":"2006","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200001273420401","article-title":"The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children","volume":"342","author":"Neuzil","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3201\/eid1201.051254","article-title":"Influenza pandemics of the 20th century","volume":"12","author":"Kilbourne","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.316.5821.49c","article-title":"Pneumococcal vaccines and flu preparedness","volume":"316","author":"Klugman","year":"2007","journal-title":"Science"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib24","first-page":"1","article-title":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10096-007-0321-5","article-title":"Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae","volume":"26","author":"Riedel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2007.01910.x_bib26","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/BF02561662","article-title":"Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe","volume":"27","author":"Debbia","year":"1999","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)70799-6","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2007.01910.x_bib29","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1093\/clinids\/24.Supplement_1.S2","article-title":"The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally","volume":"24","author":"O'Brien","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib30","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/AAC.40.9.2190","article-title":"Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network","volume":"40","author":"Simor","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib31","first-page":"1881","article-title":"Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice","volume":"44","author":"Wang","year":"1998","journal-title":"Can Fam Physician"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1469-0691.2003.00798.x","article-title":"Systemic antibiotic treatment in upper and lower respiratory tract infections: official French guidelines","volume":"9","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.7326\/0003-4819-134-6-200103200-00013","article-title":"Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods","volume":"134","author":"Gonzales","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib34","first-page":"510","article-title":"Principles of appropriate antibiotic use. Part II. Nonspecific upper respiratory tract infections","volume":"64","author":"Ressel","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1542\/peds.101.S1.181","article-title":"The common cold: principles of judicious use of antiviral agents","volume":"101","author":"Rosenstein","year":"1998","journal-title":"Pediatrics"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib36","first-page":"268","article-title":"Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database","volume":"26","author":"Ashworth","year":"2004","journal-title":"J Pub Hlth"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib37","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1001\/jama.287.23.3096","article-title":"Trends in antimicrobial prescribing rates for children and adolescents","volume":"287","author":"McCaig","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib38","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3201\/eid0904.020268","article-title":"Antimicrobial drug prescription in ambulatory care settings, United States, 1992\u20132000","volume":"9","author":"McCaig","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jac\/dkh342","article-title":"No significant decrease in antibiotic use from 1992 to 2000 in the French community","volume":"54","author":"Sommet","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib40","first-page":"267","article-title":"Antibiotics and respiratory infections: do antibiotic prescriptions improve outcomes?","volume":"89","author":"Hamm","year":"1996","journal-title":"J Okla State Med Assoc"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1023\/B:EJEP.0000036807.40105.97","article-title":"Antibiotic treatment for influenza does not affect resolution of illness, secondary visits or lost workdays","volume":"19","author":"Carrat","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.1997.03550110039033","article-title":"Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians","volume":"278","author":"Gonzales","year":"1997","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib43","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jama.1997.03550110082041","article-title":"Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients","volume":"278","author":"Schwartz","year":"1997","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib44","first-page":"148","article-title":"Antibiotic prescriptions associated with outpatient visits for acute upper respiratory tract infections among adult Medicaid recipients in North Carolina","volume":"64","author":"Brown","year":"2003","journal-title":"NC Med J"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib45","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.rmed.2004.03.021","article-title":"Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997\u20132001","volume":"98","author":"Ciesla","year":"2004","journal-title":"Respir Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00228-003-0669-0","article-title":"Exploring patient-and doctor-related variables associated with antibiotic prescribing for respiratory infections in primary care","volume":"59","author":"Mazzaglia","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/jinf.2000.0689","article-title":"Assessment of antibiotic prescription in acute respiratory infections in adults. The Spanish Study Group on Antibiotic Treatments","volume":"41","author":"Ochoa","year":"2000","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.279.11.875","article-title":"Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis","volume":"279","author":"Nyquist","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.inf.0000253062.41648.60","article-title":"Influenza burden in febrile infants and young children in a pediatric emergency department","volume":"26","author":"Ploin","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib50","first-page":"811","article-title":"The validity of a sore throat score in family practice","volume":"163","author":"McIsaac","year":"2000","journal-title":"Can Med Assoc J"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib51","first-page":"339","article-title":"Effect on antibiotic prescribing of repeated clinical prompts to use a sore throat score: lessons from a failed community intervention study","volume":"51","author":"McIsaac","year":"2002","journal-title":"J Fam Pract"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib52","first-page":"589","article-title":"Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice","volume":"46","author":"Dagnelie","year":"1996","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib53","first-page":"659","article-title":"C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis","volume":"54","author":"Bjerrum","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/oxfordjournals.epirev.a036023","article-title":"Assessing vaccine efficacy in the field. Further observations","volume":"10","author":"Orenstein","year":"1988","journal-title":"Epidemiol Rev"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib55","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jama.293.8.987","article-title":"Does this patient have influenza?","volume":"293","author":"Call","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib56","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1086\/317425","article-title":"Predicting influenza infections during epidemics with use of a clinical case definition","volume":"31","author":"Boivin","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib57","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/archinte.160.21.3243","article-title":"Clinical signs and symptoms predicting influenza infection","volume":"160","author":"Monto","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib58","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JCM.41.8.3487-3493.2003","article-title":"Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection","volume":"41","author":"Ruest","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/JCM.39.1.196-200.2001","article-title":"Simultaneous detection of influenza viruses A and B using real-time quantitative PCR","volume":"39","author":"van Elden","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib60","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl J Med"},{"issue":"suppl B","key":"10.1111\/j.1469-0691.2007.01910.x_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/44.suppl_2.23","article-title":"Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis","volume":"44","author":"Monto","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib62","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib63","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib64","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200005000-00005","article-title":"Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial","volume":"19","author":"Hedrick","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib65","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib66","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(98)10190-3","article-title":"Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079905X46214","article-title":"Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir","volume":"21","author":"Nordstrom","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archinte.161.2.212","article-title":"Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials","volume":"161","author":"Lalezari","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib70","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/505868","article-title":"A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003\u20132004 and 2004\u20132005 influenza seasons","volume":"43","author":"Kawai","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(01)00215-7","article-title":"Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo","volume":"54","author":"Carr","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib72","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","article-title":"The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leaves virus severely compromised both in vitro and in vivo","volume":"55","author":"Ives","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib73","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1086\/424572","article-title":"Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets","volume":"190","author":"Herlocher","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0166-3542(01)00214-5","article-title":"Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets","volume":"54","author":"Herlocher","year":"2002","journal-title":"Antiviral Res"},{"key":"10.1111\/j.1469-0691.2007.01910.x_bib75","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance","volume":"337","author":"Seppala","year":"1997","journal-title":"N Engl J Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14628007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14628007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T21:24:46Z","timestamp":1684272286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14628007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1198743X14628007"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01910.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}